EBS - Emergent to sell Baltimore-Camden production site for $30M
2024-06-20 09:26:46 ET
More on Emergent Biosolutions
- Emergent BioSolutions: High-Risk, High-Reward Strategic Turnaround
- Emergent BioSolutions Inc. (EBS) Q1 2024 Earnings Call Transcript
- Emergent BioSolutions Inc. 2024 Q1 - Results - Earnings Call Presentation
- Walgreens launches its own opioid reversal therapy for OTC use
- Emergent BioSolutions gains as results top estimates, co to cut 300 jobs